As your partner in early clinical drug development, our Aepodia team helps you to establish an optimal early-phase clinical research strategy and plan. All relevant pharmaceutical, pharmacological, efficacy, toxicology and metabolism preclinical and clinical information are evaluated to implement a clinical development plan to rapidly reach a go/no go decision. Studies address primary objectives and help make sure the compound or medical device moves forward to the next critical decision point.

Need more information from the seller?

Share on: